BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma

BackgroundsImmunotherapy is effective in a subset of head and neck squamous cell carcinoma (HNSCC). However, the unfavorable response rate and inadequate biomarkers for stratifying patients have primarily limited its clinical application. Considering transcriptional factors (TFs) play essential role...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Xue Pan, Xun Xu, Lixuan Wang, Siyuan Zhang, Yingyao Chen, Rongchun Yang, Xijuan Chen, Bin Cheng, Juan Xia, Xianyue Ren
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-01-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	HNSCC BASP1 immunotherapy CD8+ T cells ferroptosis
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1021262/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!